Related Experiment Video

Updated: Oct 13, 2025

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
09:03

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic

Published on: November 7, 2020

5.1K

The COVID-19 pandemic in a paediatric population: A health care perspective

Viral P Maru1, Salil Bapat2

  • 1Department of Paediatric and Preventive Dentistry, Government Dental College and Hospital, Mumbai, India.

Journal of Mother and Child
|November 17, 2021
PubMed

Insights

This review examines Coronavirus disease 2019 (COVID-19) in children, highlighting limited data on pediatric infection. It aims to inform public health policies for child safety during the pandemic.

Area of Science:

  • Virology
  • Epidemiology
  • Public Health

Background:

  • Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) caused the COVID-19 pandemic.
  • Children contract COVID-19 through direct exposure or airborne droplets, often from infected households.
  • Pediatric COVID-19 cases represent less than 5% globally, with limited research available.

Purpose of the Study:

  • To systematically review the epidemiology of COVID-19 in pediatric populations.
  • To analyze clinical features, diagnostic outcomes, and management strategies for children with COVID-19.
  • To provide evidence-based recommendations for clinical and public health policies concerning pediatric COVID-19.

Main Methods:

  • Systematic review methodology.
  • Data extraction on pediatric COVID-19 cases.
  • Analysis of epidemiological and clinical data.

Main Results:

  • Inadequate data exists regarding COVID-19 infection in children.
  • Understanding pediatric COVID-19 requires further investigation.
  • The review synthesizes current knowledge on pediatric COVID-19.

Conclusions:

  • Further research is crucial to address data gaps in pediatric COVID-19.
  • This review informs policy decisions for protecting children globally.
  • Evidence-based strategies are needed for managing COVID-19 in pediatric populations.

Keywords:
COVID-19Paediatric health carePaediatric population

More Related Videos

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

2.9K
Setup of Consumer Wearable Devices for Exposure and Health Monitoring in Population Studies15:00

Setup of Consumer Wearable Devices for Exposure and Health Monitoring in Population Studies

Published on: February 3, 2023

2.7K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
24
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
22
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
21
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
31
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.6K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
35